home *** CD-ROM | disk | FTP | other *** search
- Newsgroups: alt.drugs
- From: an13187@anon.penet.fi (H-Man)
- Subject: mdma article #10 (final)
- Message-ID: <1993Jul4.032822.25782@fuug.fi>
- Date: Sat, 3 Jul 1993 17:53:19 GMT
-
- JAMA(R) 1988; 260: 1791
-
- September 23, 1988 / September 30, 1988
-
- SECTION: BOOKS
-
- LENGTH: 500 words
-
- TITLE: Designer Drugs, By M. M. Kirsch, 176 pp. $ 7.95, Minneapolis, CompCare
- Publications, 1986.
-
- AUTHOR: Peter L. Putnam, MD, MPH, Washington, DC
-
- ED/SECT: Edited by Harriet S. Meyer, MD, Contributing Editor; adviser for
- software, Robert Hogan, MD, San Diego.
-
- TEXT:
- Designer drugs, like designer clothes, are produced to sell. They are
- created and marketed to a clientele of growing size that is looking for an ever
- more varied or specific experience in a recreational drug. The designer
- drug is usually a variation on a previously controlled substance.
-
- These drugs, which are manufactured by altering the chemical structure of
- narcotics, stimulants, or other recreational drugs, produce similar effects.
- Often, as in the case of " Ecstasy, " the effect is preferred to that of the
- original drug.
-
- Crack has been successfully marketed because its use replaces free-basing
- in convenient form. It is easily produced from cocaine with little
- equipment. Similarly, phencyclidine (PCP) can be produced in almost any home
- or garage laboratory by anyone who is willing and able to follow a simple
- cookbook.
-
- Synthetic narcotics many times as potent as natural narcotics can be
- produced by a chemist who has a little skill and ingenuity. This book, in
- fact, describes one such chemist who apparently grew tired of working for
- the salary he received from a large chemical company.
-
- It is clear that the drugs described, such as "Ectasy," "crack," "dust,"
- "china white," and MPTP (methylphenyltetrahydropyridine), represent a serious
- health menace -- some because of the unknown potency and ease of overdose (such
- as the fentanyl derivatives), some because of the inherent quality of the drug
- itself (such as PCP), and others because of poor manufacturing techniques (such
- as the fenantyl derivatives) that produce toxic analogues.
-
- The book uses generous excerpts from a variety of sources, including the
- producers, distributors, users, and law enforcement officers. Even though
- there are vivid descriptions of the risks involved in the use of such drugs,
- it will come as no surprise to the reader that there is convincing evidence
- in this book that the manufacture, distribution, and sales of these drugs
- are a well-established business worth billions of dollars.
-
- This business has grown despite all attempts at federal and local
- interdiction. It is not surprising, therefore, that the authors have
- concluded that the way to stop the drug trade is not by increased police and
- military action to halt manufacture and distribution but by means that will
- reduce the demand. The book goes so far as to suggest that the most important
- thing that prohibition has done has been to increase the price and profit in
- the drug trade. The focus of intervention would be on increasing a sense of
- individual responsibility and public awareness of the risks involved in drug
- use.
-
- This is not a clinical handbook and is of little value in the recognition
- and treatment of chemical dependence. It is of significance in that it might
- promote a rational debate about the issues. Certainly on these issues, as
- physicians, we should be part of an informed electorate. It is quite clear
- that the rhetoric of our representatives is often more emotional than
- rational.
- -------------------------------------------------------------------------
- To find out more about the anon service, send mail to help@anon.penet.fi.
- Due to the double-blind, any mail replies to this message will be anonymized,
- and an anonymous id will be allocated automatically. You have been warned.
- Please report any problems, inappropriate use etc. to admin@anon.penet.fi.
-
-
-